Acridine derivatives activate p53 and induce tumor cell death through Bax.

scientific article published on August 2005

Acridine derivatives activate p53 and induce tumor cell death through Bax. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4161/CBT.4.8.2134
P698PubMed publication ID16177561
P5875ResearchGate publication ID7585586

P50authorWafik El-DeiryQ4118647
P2093author name stringRonen Marmorstein
Jeffrey D Winkler
Wenge Wang
David T Dicker
William C Ho
Colin MacKinnon
P433issue8
P921main subjectcell deathQ2383867
P304page(s)893-898
P577publication date2005-08-01
P1433published inCancer Biology and TherapyQ2544651
P1476titleAcridine derivatives activate p53 and induce tumor cell death through Bax
P478volume4

Reverse relations

cites work (P2860)
Q374073229-AAA inhibits growth and induces apoptosis in human melanoma A375 and rat prostate adenocarcinoma AT-2 and Mat-LyLu cell lines but does not affect the growth and viability of normal fibroblasts
Q42256808AAVPG: a vigilant vector where transgene expression is induced by p53.
Q38213469Acridine and its derivatives: a patent review (2009 - 2013).
Q39273277Amsacrine-induced apoptosis of human leukemia U937 cells is mediated by the inhibition of AKT- and ERK-induced stabilization of MCL1.
Q28483751Anti-cancer activity of a novel small molecule compound that simultaneously activates p53 and inhibits NF-κB signaling
Q28743513Beyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers
Q36717985Biological clues to potent DNA-damaging activities in food and flavoring
Q36173604CP-31398 restores mutant p53 tumor suppressor function and inhibits UVB-induced skin carcinogenesis in mice
Q40107748CR229, a novel derivative of beta-carbolin-1-one, induces cell cycle arrest and apoptosis in HeLa cells via p53 activation
Q33642043Characterization and optimization of a novel protein-protein interaction biosensor high-content screening assay to identify disruptors of the interactions between p53 and hDM2.
Q39712685Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53 independent
Q33767881Combination of 9-aminoacridine with Campath-1H provides effective therapy for a murine model of adult T-cell leukemia
Q37337951Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-kappaB pathways.
Q36917788Identification of a Small Molecule That Overcomes HdmX-Mediated Suppression of p53.
Q30985752Implementation of a 220,000-compound HCS campaign to identify disruptors of the interaction between p53 and hDM2 and characterization of the confirmed hits
Q40059572In vitro effects of Plasmodium falciparum dihydrofolate reductase inhibitors on normal and cancer cell proliferation.
Q22122025Molecular imaging in drug development
Q37878209Natural and synthetic acridines/acridones as antitumor agents: their biological activities and methods of synthesis.
Q47974412Non-genotoxic activation of p53 through the RPL11-dependent ribosomal stress pathway.
Q37769295Oxygenomics in environmental stress.
Q41831176Oxymatrine inhibits proliferation of human bladder cancer T24 cells by inducing apoptosis and cell cycle arrest
Q28480949Pharmacokinetics of quinacrine efflux from mouse brain via the P-glycoprotein efflux transporter
Q37191174Pharmacological activation of p53 in cancer cells
Q35127004Quinacrine Inhibits Cell Growth and Induces Apoptosis in Human Gastric Cancer Cell Line SGC-7901.
Q38702241Quinacrine in endometrial cancer: Repurposing an old antimalarial drug
Q36546665Quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth
Q37664869The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals
Q30318847The novel calcineurin inhibitor CN585 has potent immunosuppressive properties in stimulated human T cells.

Search more.